Spine Oncology: Improving Outcomes through Innovation

Glucagon-Like Peptide-1 Receptor Agonist Use Significantly Reduces Primary Malignant Brain Tumor Risk: A Propensity-Matched Analysis of 415,548 Patients with Type 2 Diabetes

Sunday, April 27, 2025

2:34 PM – 2:39 PM EDT

Presenting Author(s)